Cited by 17Schizophrenia research and treatmentStatistical Methods in Clinical TrialsMental Health Treatment and Access

Universal prevention of schizophrenia and surrogate endpoints at population level

Open access
Szöke, A., Kirkbride, J. B., Schürhoff, F.·2014·Social Psychiatry and Psychiatric Epidemiology

Abstract

Despite significant progresses in our knowledge of the risk factors for schizophrenia, we still are several steps short of implementing effective prevention strategies. Universal prevention strategies have several theoretical advantages but their implementation has been limited to date by their costs and lack of methods to assess their efficiency. To overcome this limitation, we suggest, based on research from therapeutic trials at individual level, the use of surrogate endpoints (SEs) at population level. We further suggest that subclinical measures of psychosis at population level are good SEs candidates for assessing universal measures for schizophrenia prevention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00127-014-0829-9

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Szöke, A., Kirkbride, J. B., & Schürhoff, F.
Affiliations
  • Inserm (FR)
  • University of Cambridge (GB)
Corresponding author
Szöke, A.
Venue
Social Psychiatry and Psychiatric Epidemiology
Published
2014-02-02
Volume
49
Issue
9
Pages
1347-1351
ISSN
  • 0933-7954 (ISSN-L)
  • 1433-9285
OpenAlex
W1976287357
Cited by
17
References
17
Citations by year
2025: 1 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 1 · 2018: 2 · 2017: 2 · 2016: 2
Type
journal article
Language
en
Open access
Locations
  • Social Psychiatry and Psychiatric Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Wellcome Trust (101272)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
schizophrenia, universal prevention, surrogate endpoints, population-level prevention, subclinical psychosis, psychosis risk factors
MeSH terms
Humans, Risk Factors, Schizophrenia, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review